Search results
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 4 days agoWhether she was joking or not, she viewed the job as temporary—a way to get by before she resumed...
Jazz Pharmaceuticals stock maintains Outperform rating By Investing.com
Investing.com· 2 days agoOn Thursday, RBC (TSX:RY) Capital Markets sustained its Outperform rating and $176.00 price target...
Male Birth Control Gel Is Proving Safe and Effective in Early Clinical Trials
Teen Vogue via Yahoo News· 2 days agoOffice, and as of yet, this research project has no commercial partner to assist with costs. “No ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 17 hours agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol...
Benzinga· 3 days agoWednesday, Adial Pharmaceuticals Inc. ADIL announced that the first patient had been dosed in a pharmacokinetics study of AD04 for Alcohol Use Disorder in heavy drinking patients ...
FDA panel to review psychedelic drug MDMA for first time
Reuters· 4 days agoThe meeting by the agency's independent experts is the farthest that a drug based on MDMA, commonly...
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
CNBC· 5 days agoCompany logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 5 days agoTelix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics...Application (BLA) to the United States ( ...
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
Morningstar· 4 days agoRANCHO CUCAMONGA, CA / ACCESSWIRE / June 4, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that on June 3, 2024, the Company's Board...ANDAs") on file ...
SciTech Development secures additional funding for cancer trials
Clinical Trials Arena via Yahoo Finance· 3 days agoThe nanoparticalised delivery platform (SDP) addresses previous bioavailability issues and mitigates...
